Melanoma/Skin Cancer

Top Story

Post-transplant squamous cell carcinoma incidence declined in recent years

October 20, 2017

There has been a consistent decline in squamous cell carcinoma post-transplant among organ transplant recipients in Norway since the 1980s, according to recent findings.

The population-based, nationwide, prospective cohort study included 8,026 patients who underwent a solid organ transplant after late-stage organ failure from 1968 to 2012. Eligible participants had received a kidney, heart, lung or liver transplant, and were subsequently treated with immunosuppressive therapy.

In the Journals

One in five young women dependent on indoor tanning

October 19, 2017
Data from a recent survey demonstrate indoor tanning dependence was linked with symptoms of depression and beliefs about physical appearance. The cross-sectional…

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

October 17, 2017
Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized…
FDA News

FDA grants priority review to Opdivo for resected, high-risk melanoma

October 17, 2017
The FDA granted priority review to nivolumab for the treatment of patients with melanoma who are at high risk for disease recurrence following complete surgical…
More Headlines »

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »

Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis

September 25, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress


Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed…
More »